Notice: Trying to access array offset on value of type null in /home/capitalwired/public_html/wp-content/plugins/really-simple-facebook-twitter-share-buttons/really-simple-facebook-twitter-share-buttons.php on line 318
A recent study revealed that a few commonly used arthritis drugs can increase the risk of death in patients.
The experts examined some COX-2 inhibitors such as elecoxib, diclofenac, nabumeton, meloxicam and etodolac. Some of these medicines are widely known as Celebrex and Lodine.
The experts of Aarhus University Hospital analyzed the medical data of nearly 100,243 patients. All of these patients suffered from the first stroke in between the 2004 and 2012.
Moreover, they closely studied the medical history of these patients. They determined the exact time period in which doctors prescribed them COX-2 inhibitors.
The study unveiled a strong association of COX-2 inhibitors and strokes and patients. The people who take COX-2 inhibitors are more at a risk of death after first stroke as compared to the ordinary patients. They figured out that approximately 19 percent of people who use COX-2 inhibitors die after their first stroke
It is important to bear in mind that these researchers do not look for any kind of cause and effect relationship between the drug and stroke. They merely discovered the connection between death and these drugs.
Moreover, the study unveiled that etodolac increase the chances of mortality in patients up to 53 percent. However, they do not find any particular connection between “non-selective” NSAIDs and stroke death.
Dr. Morten Schmidt, the lead author of this research stated that the chief purpose of this study is to make certain that people with a higher risk of stroke should not use these medicines.